The receptor binding domain of botulinum neurotoxin serotype A (BoNT/A) inhibits BoNT/A and BoNT/E intoxications in vivo.
about
Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin DrugsRole of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody PreparationsThe C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxinA mutated recombinant subunit vaccine protects mice and guinea pigs against botulinum type A intoxication.
P2860
The receptor binding domain of botulinum neurotoxin serotype A (BoNT/A) inhibits BoNT/A and BoNT/E intoxications in vivo.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The receptor binding domain of ...... BoNT/E intoxications in vivo.
@en
The receptor binding domain of botulinum neurotoxin serotype A
@nl
type
label
The receptor binding domain of ...... BoNT/E intoxications in vivo.
@en
The receptor binding domain of botulinum neurotoxin serotype A
@nl
prefLabel
The receptor binding domain of ...... BoNT/E intoxications in vivo.
@en
The receptor binding domain of botulinum neurotoxin serotype A
@nl
P2093
P2860
P356
P1476
The receptor binding domain of ...... BoNT/E intoxications in vivo.
@en
P2093
Ada Barnea
Alon Ben David
Amram Torgeman
Eran Diamant
Osnat Rosen
Ran Zichel
P2860
P304
P356
10.1128/CVI.00268-13
P577
2013-06-12T00:00:00Z